Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study

Publication
The Lancet Oncology
Jens Kleesiek
Jens Kleesiek
Professor of Translational Image-guided Oncology
Ken Herrmann
Ken Herrmann
Chair Department of Nuclear Medicine